Lawrence J. Waldman - 30 Jun 2026 Form 4 Insider Report for Apyx Medical Corp (APYX)

Reporting relationship: Director
Issuer ticker: APYX
Reported as of: 30 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Jul 2026, 17:00:23 UTC
Prior SEC filing: 15 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Lawrence J. Waldman

Key filing fact

Lawrence J. Waldman filed Form 4 for Apyx Medical Corp (APYX) on 02 Jul 2026.

Key facts

This page summarizes Lawrence J. Waldman's Form 4 filing for Apyx Medical Corp (APYX).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 02 Jul 2026, 17:00.

Change

Previous filing in this sequence was filed on 15 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001516592 Primary reporting owner

Waldman Lawrence

Relationship: Director
Address: C/O APYX MEDICAL CORPORATION, 5115 ULMERTON ROAD, CLEARWATER
Signature: /s/ Lawrence J. Waldman
Signature date: 02 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

APYX transaction

Common Stock

Options Exercise

Transaction value
Shares: +12,000
Change %: +225%
Price: $1.88^*
Shares after: 17,338
Date: 30 Jun 2026
Ownership: By SLAT
Footnotes: F1

APYX transaction

Common Stock

Tax liability

Transaction value
Shares: -5,024
Change %: -29%
Price: $4.49^*
Shares after: 12,314
Date: 30 Jun 2026
Ownership: By SLAT
Footnotes: F1

APYX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 37,563
Date: 30 Jun 2026
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

APYX transaction Derivative

Stock option (right to buy)

Options Exercise

Transaction value
Shares: -12,000
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 30 Jun 2026
Ownership: By SLAT
Underlying class: Common Stock
Underlying amount: 12,000
Exercise price: $1.88
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Held by a Spousal Lifetime Access Trust (the "SLAT"). The Reporting Person's spouse and children are trustees of the SLAT. The Reporting Person disclaims beneficial ownership of all securities held by the SLAT, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein, if any.

Footnote F2

On June 30, 2026, the Reporting Person effected a net exercise of 12,000 stock options with an exercise price of $1.88 per share. Pursuant to the terms of the exercise, 5,024 shares otherwise issuable upon exercise were withheld by the issuer at a value of $4.49 per share to satisfy the aggregate exercise price, resulting in the issuance of 6,976 net shares to the Reporting Person.